Caris Life Sciences, Inc. 4

Director-level insider George Poste received 1,600 shares of Caris Life Sciences, Inc. common stock as equity compensation in place of cash board retainer fees.

On May 29, 2026, reporting person George Poste received 1,600 shares of Caris Life Sciences, Inc. common stock at an implied price of $15.62 per share, issued in lieu of cash compensation for his 2026 board retainer fees, increasing his directly held stake to 17,729 shares while also holding an additional 511,702 shares indirectly through a family trust, with no change to his aggregate beneficial ownership from a prior transfer to that trust.

Filing Facts

CIK

2019410

Ticker

CAI

Form

4

Source Type

sec

Accession

0001180770-26-000003

Alert Tier

5